Breaking News

Adidas to Start EU1.5B Shareholder Return Program
Tweet TWEET

Dynavax to Present at the William Blair 2014 Growth Stock Conference

Dynavax to Present at the William Blair 2014 Growth Stock Conference  BERKELEY, CA -- (Marketwired) -- 06/09/14 --  Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it will present at the William Blair 2014 Growth Stock Conference in Chicago on Wednesday, June 11, 2014 at 2:40 p.m. Central Time (12:40 p.m. Pacific Time).   Eddie Gray, Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at http://investors.dynavax.com/newsevents.cfm.   About Dynavax  Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidate is HEPLISAV-B(TM), a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com.  Contact: Michael Ostrach Chief Business and Principal Financial Officer  510-665-7257 mostrach@dynavax.com     
Press spacebar to pause and continue. Press esc to stop.